Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • OKTA vs GSK✓SelectedUSD · GSKOKTA vs GSK performance historyLatest closeAs of+12.07%11/18
Stock and ETF performance explorer

OKTA vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
-26.0%
GSK return
+42.7%
Excess return
-68.7%
Maximum drawdown
-83.0%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 5y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D+12.1%-1.3%+13.4%+12.2%
7D+7.3%-3.1%+10.5%+7.7%
30D+3.0%-0.9%+3.9%+3.1%
3M+35.9%-4.2%+40.1%+36.4%
6M+124.7%-1.6%+126.3%+123.7%
YTD+126.2%+2.6%+123.6%+120.1%
1Y+141.4%+6.2%+135.2%+132.7%
3Y+178.6%+55.0%+123.6%+135.2%
5Y-26.0%+42.8%-68.8%-41.2%
All-26.0%+42.7%-68.7%-41.2%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 5y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

5y analysis · Full analysis span regression · 6 months rolling